SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031623
Filing Date
2022-11-14
Accepted
2022-11-14 08:01:05
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1041153
2 ex31-1.htm EX-31.1 17792
3 ex31-2.htm EX-31.2 17865
4 ex32-1.htm EX-32.1 7436
5 ex32-2.htm EX-32.2 7514
  Complete submission text file 0001493152-22-031623.txt   4836800

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT foxw-20220930.xsd EX-101.SCH 35381
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT foxw-20220930_cal.xml EX-101.CAL 38346
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT foxw-20220930_def.xml EX-101.DEF 196672
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT foxw-20220930_lab.xml EX-101.LAB 271764
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT foxw-20220930_pre.xml EX-101.PRE 229066
45 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 791527
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39891 | Film No.: 221380422
SIC: 2834 Pharmaceutical Preparations